FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2736236310> ?p ?o ?g. }

• W2736236310 endingPage "601" @default.
• W2736236310 startingPage "594" @default.
• W2736236310 abstract "Objective: To investigate whether creatine administration could slow progressive functional decline in adults with early symptoms of Huntington disease. Methods: We conducted a multicenter, randomized, double-blind, placebo-controlled study of up to 40 g daily of creatine monohydrate in participants with stage I and II HD treated for up to 48 months. The primary outcome measure was the rate of change in total functional capacity (TFC) between baseline and end of follow-up. Secondary outcome measures included changes in additional clinical scores, tolerability, and quality of life. Safety was assessed by adverse events and laboratory studies. Results: At 46 sites in North America, Australia, and New Zealand, 553 participants were randomized to creatine (275) or placebo (278). The trial was designed to enroll 650 patients, but was halted for futility after the first interim analysis. The estimated rates of decline in the primary outcome measure (TFC) were 0.82 points per year for participants on creatine, 0.70 points per year for participants on placebo, favoring placebo (nominal 95% confidence limits −0.11 to 0.35). Adverse events, mainly gastrointestinal, were significantly more common in participants on creatine. Serious adverse events, including deaths, were more frequent in the placebo group. Subgroup analysis suggested that men and women may respond differently to creatine treatment. Conclusions: Our data do not support the use of creatine treatment for delaying functional decline in early manifest HD. Clinicaltrials.gov identifier: NCT00712426. Classification of evidence: This study provides Class II evidence that for patients with early symptomatic HD, creatine monohydrate is not beneficial for slowing functional decline." @default.
• W2736236310 created "2017-07-21" @default.
• W2736236310 creator A5005126973 @default.
• W2736236310 creator A5014443802 @default.
• W2736236310 creator A5016461885 @default.
• W2736236310 creator A5017422398 @default.
• W2736236310 creator A5024433352 @default.
• W2736236310 creator A5032351341 @default.
• W2736236310 creator A5054261106 @default.
• W2736236310 creator A5087201376 @default.
• W2736236310 date "2017-07-12" @default.
• W2736236310 modified "2023-10-18" @default.
• W2736236310 title "The CREST-E study of creatine for Huntington disease" @default.
• W2736236310 cites W144849882 @default.
• W2736236310 cites W1750171938 @default.
• W2736236310 cites W1797863618 @default.
• W2736236310 cites W1968540840 @default.
• W2736236310 cites W1970437863 @default.
• W2736236310 cites W1972633070 @default.
• W2736236310 cites W1997883336 @default.
• W2736236310 cites W2004565920 @default.
• W2736236310 cites W2020117714 @default.
• W2736236310 cites W2053643668 @default.
• W2736236310 cites W2067856511 @default.
• W2736236310 cites W2076413986 @default.
• W2736236310 cites W2117249078 @default.
• W2736236310 cites W2119763594 @default.
• W2736236310 cites W2122459736 @default.
• W2736236310 cites W2125591463 @default.
• W2736236310 cites W2130013510 @default.
• W2736236310 cites W2135344915 @default.
• W2736236310 cites W2147480509 @default.
• W2736236310 cites W2152847494 @default.
• W2736236310 cites W2163827910 @default.
• W2736236310 cites W2276349622 @default.
• W2736236310 cites W2358364508 @default.
• W2736236310 cites W2606710341 @default.
• W2736236310 cites W79347247 @default.
• W2736236310 doi "https://doi.org/10.1212/wnl.0000000000004209" @default.
• W2736236310 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5562960" @default.
• W2736236310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28701493" @default.
• W2736236310 hasPublicationYear "2017" @default.
• W2736236310 type Work @default.
• W2736236310 sameAs 2736236310 @default.
• W2736236310 citedByCount "55" @default.
• W2736236310 countsByYear W27362363102017 @default.
• W2736236310 countsByYear W27362363102018 @default.
• W2736236310 countsByYear W27362363102019 @default.
• W2736236310 countsByYear W27362363102020 @default.
• W2736236310 countsByYear W27362363102021 @default.
• W2736236310 countsByYear W27362363102022 @default.
• W2736236310 countsByYear W27362363102023 @default.
• W2736236310 crossrefType "journal-article" @default.
• W2736236310 hasAuthorship W2736236310A5005126973 @default.
• W2736236310 hasAuthorship W2736236310A5014443802 @default.
• W2736236310 hasAuthorship W2736236310A5016461885 @default.
• W2736236310 hasAuthorship W2736236310A5017422398 @default.
• W2736236310 hasAuthorship W2736236310A5024433352 @default.
• W2736236310 hasAuthorship W2736236310A5032351341 @default.
• W2736236310 hasAuthorship W2736236310A5054261106 @default.
• W2736236310 hasAuthorship W2736236310A5087201376 @default.
• W2736236310 hasBestOaLocation W27362363101 @default.
• W2736236310 hasConcept C126322002 @default.
• W2736236310 hasConcept C142724271 @default.
• W2736236310 hasConcept C168563851 @default.
• W2736236310 hasConcept C1862650 @default.
• W2736236310 hasConcept C197934379 @default.
• W2736236310 hasConcept C203092338 @default.
• W2736236310 hasConcept C204787440 @default.
• W2736236310 hasConcept C27081682 @default.
• W2736236310 hasConcept C2778375690 @default.
• W2736236310 hasConcept C2779134260 @default.
• W2736236310 hasConcept C2779896295 @default.
• W2736236310 hasConcept C2780647506 @default.
• W2736236310 hasConcept C2910054578 @default.
• W2736236310 hasConcept C61943457 @default.
• W2736236310 hasConcept C71924100 @default.
• W2736236310 hasConceptScore W2736236310C126322002 @default.
• W2736236310 hasConceptScore W2736236310C142724271 @default.
• W2736236310 hasConceptScore W2736236310C168563851 @default.
• W2736236310 hasConceptScore W2736236310C1862650 @default.
• W2736236310 hasConceptScore W2736236310C197934379 @default.
• W2736236310 hasConceptScore W2736236310C203092338 @default.
• W2736236310 hasConceptScore W2736236310C204787440 @default.
• W2736236310 hasConceptScore W2736236310C27081682 @default.
• W2736236310 hasConceptScore W2736236310C2778375690 @default.
• W2736236310 hasConceptScore W2736236310C2779134260 @default.
• W2736236310 hasConceptScore W2736236310C2779896295 @default.
• W2736236310 hasConceptScore W2736236310C2780647506 @default.
• W2736236310 hasConceptScore W2736236310C2910054578 @default.
• W2736236310 hasConceptScore W2736236310C61943457 @default.
• W2736236310 hasConceptScore W2736236310C71924100 @default.
• W2736236310 hasIssue "6" @default.
• W2736236310 hasLocation W27362363101 @default.
• W2736236310 hasLocation W27362363102 @default.
• W2736236310 hasLocation W27362363103 @default.
• W2736236310 hasLocation W27362363104 @default.
• W2736236310 hasLocation W27362363105 @default.

• next